English

Sierra Oncology, Inc.

EDGAR

DNAI Quarterly report (10-Q) · filed 2022-05-06

34 filing records in this dataset, filed from 2015-06-12 to 2022-05-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 274 million USD 2022-03-31 Source
Exact value

274015000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 23.8 million shares 2022-03-31 Source
Exact value

23800409 shares

Reported share-count change

92.72% · 11.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

12349961 shares · 2021-03-31· Source
23800409 shares · 2022-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-103 million USD

2021-04-01 – 2022-03-31

Exact inputs and evidence

Net income: -20630000 USD · 2021-04-01 – 2021-06-30 Source
Net income: -28647000 USD · 2021-07-01 – 2021-09-30 Source
Net income: -94659000 USD · 2021-01-01 – 2021-12-31 Source
Net income: -69192000 USD · 2021-01-01 – 2021-09-30 Source
Net income: -27928000 USD · 2022-01-01 – 2022-03-31 Source

Operating cash flow

-87.7 million USD

2021-04-01 – 2022-03-31

Exact inputs and evidence

Operating cash flow: -33966000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -16961000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: -63714000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -33966000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: -78964000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: -63714000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: -25737000 USD · 2022-01-01 – 2022-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-05-06.

Financial data available through: 2021-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 9 of 11 periods available· newest 2021-12-31
Net income: 9 of 11 periods available· newest 2021-12-31
Operating cash flow: 9 of 11 periods available· newest 2021-12-31
Capital expenditure: 9 of 11 periods available· newest 2021-12-31
Total assets: 8 of 11 periods available· newest 2021-12-31
Total liabilities: 8 of 11 periods available· newest 2021-12-31
Current assets: 8 of 11 periods available· newest 2021-12-31
Current liabilities: 8 of 11 periods available· newest 2021-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2021-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 13.76 million

Prior period

−USD 80.9 million

2020-01-01 – 2020-12-31
Current period

−USD 94.66 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-94659000 − -80902000 = -13757000 USD

-80902000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-94659000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Year-over-year change in Net income: -13757000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -94659000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#1992906 Filing: 000156459022009473 Input fundies:NetIncome: -80902000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#1916896 Filing: 000156459022009473
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 26.6 million

Prior period

−USD 52.37 million

2020-01-01 – 2020-12-31
Current period

−USD 78.96 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

-78964000 − -52367000 = -26597000 USD

-52367000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
-78964000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Year-over-year change in Operating cash flow: -26597000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -78964000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2099658 Filing: 000156459022009473 Input fundies:OperatingCashFlow: -52367000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2101631 Filing: 000156459022009473
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+500%

Prior period

USD 12,000

2020-01-01 – 2020-12-31
Current period

USD 72,000

2021-01-01 – 2021-12-31

Exact inputs and evidence

72000 − 12000 = 60000 USD

12000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
72000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Year-over-year change in Capital expenditure: 60000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 72000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2111249 Filing: 000156459022009473 Input fundies:CapitalExpenditure: 12000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2113116 Filing: 000156459022009473
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 6.83 million Exact value Exact value: -6832000 USD 2013-01-01 – 2013-12-31: -6832000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2013-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -6832000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6832000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312516490742/dnai-20151231.xml#114172 Filing: 000119312516490742 The citation records this snapshot. The page link may show a newer release later.	−USD 3.57 million Exact value Exact value: -3572000 USD 2013-01-01 – 2013-12-31: -3572000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2013-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -3572000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3572000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312516490742/dnai-20151231.xml#109676 Filing: 000119312516490742 The citation records this snapshot. The page link may show a newer release later.	USD 2,000 Exact value Exact value: 2000 USD 2013-01-01 – 2013-12-31: 2000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2013-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 2000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312516490742/dnai-20151231.xml#113909 Filing: 000119312516490742 The citation records this snapshot. The page link may show a newer release later.	−USD 3.57 million Calculation and evidence -3572000 − 2000 USD Exact free cash flow: -3574000 USD 2013-01-01 – 2013-12-31: -3572000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 2000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2013-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -3574000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3572000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312516490742/dnai-20151231.xml#109676 Filing: 000119312516490742 Input fundies:CapitalExpenditure: 2000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312516490742/dnai-20151231.xml#113909 Filing: 000119312516490742 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 23.87 million Exact value Exact value: -23873000 USD 2014-01-01 – 2014-12-31: -23873000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2014-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -23873000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23873000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312517066582/srra-20161231.xml#81384 Filing: 000119312517066582 The citation records this snapshot. The page link may show a newer release later.	−USD 21.79 million Exact value Exact value: -21786000 USD 2014-01-01 – 2014-12-31: -21786000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2014-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -21786000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21786000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312517066582/srra-20161231.xml#85038 Filing: 000119312517066582 The citation records this snapshot. The page link may show a newer release later.	USD 187,000 Exact value Exact value: 187000 USD 2014-01-01 – 2014-12-31: 187000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2014-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 187000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 187000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312517066582/srra-20161231.xml#85576 Filing: 000119312517066582 The citation records this snapshot. The page link may show a newer release later.	−USD 21.97 million Calculation and evidence -21786000 − 187000 USD Exact free cash flow: -21973000 USD 2014-01-01 – 2014-12-31: -21786000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 187000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2014-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -21973000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21786000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312517066582/srra-20161231.xml#85038 Filing: 000119312517066582 Input fundies:CapitalExpenditure: 187000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312517066582/srra-20161231.xml#85576 Filing: 000119312517066582 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 53.26 million Exact value Exact value: -53260000 USD 2015-01-01 – 2015-12-31: -53260000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2015-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -53260000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53260000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312518059374/srra-20171231.xml#87027 Filing: 000119312518059374 The citation records this snapshot. The page link may show a newer release later.	−USD 28.27 million Exact value Exact value: -28265000 USD 2015-01-01 – 2015-12-31: -28265000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2015-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -28265000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28265000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312518059374/srra-20171231.xml#85912 Filing: 000119312518059374 The citation records this snapshot. The page link may show a newer release later.	USD 414,000 Exact value Exact value: 414000 USD 2015-01-01 – 2015-12-31: 414000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2015-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 414000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 414000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312518059374/srra-20171231.xml#88795 Filing: 000119312518059374 The citation records this snapshot. The page link may show a newer release later.	−USD 28.68 million Calculation and evidence -28265000 − 414000 USD Exact free cash flow: -28679000 USD 2015-01-01 – 2015-12-31: -28265000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 414000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2015-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -28679000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28265000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312518059374/srra-20171231.xml#85912 Filing: 000119312518059374 Input fundies:CapitalExpenditure: 414000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312518059374/srra-20171231.xml#88795 Filing: 000119312518059374 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 47.87 million Exact value Exact value: -47867000 USD 2016-01-01 – 2016-12-31: -47867000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2016-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -47867000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47867000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312519055556/srra-20181231.xml#721012 Filing: 000119312519055556 The citation records this snapshot. The page link may show a newer release later.	−USD 41.16 million Exact value Exact value: -41163000 USD 2016-01-01 – 2016-12-31: -41163000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2016-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -41163000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41163000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312519055556/srra-20181231.xml#720743 Filing: 000119312519055556 The citation records this snapshot. The page link may show a newer release later.	USD 214,000 Exact value Exact value: 214000 USD 2016-01-01 – 2016-12-31: 214000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2016-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 214000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 214000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312519055556/srra-20181231.xml#722133 Filing: 000119312519055556 The citation records this snapshot. The page link may show a newer release later.	−USD 41.38 million Calculation and evidence -41163000 − 214000 USD Exact free cash flow: -41377000 USD 2016-01-01 – 2016-12-31: -41163000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 214000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2016-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -41377000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41163000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312519055556/srra-20181231.xml#720743 Filing: 000119312519055556 Input fundies:CapitalExpenditure: 214000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312519055556/srra-20181231.xml#722133 Filing: 000119312519055556 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 42.02 million Exact value Exact value: -42015000 USD 2017-01-01 – 2017-12-31: -42015000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2017-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -42015000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42015000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312520059703/srra-20191231.xml#393469 Filing: 000119312520059703 The citation records this snapshot. The page link may show a newer release later.	−USD 36.16 million Exact value Exact value: -36163000 USD 2017-01-01 – 2017-12-31: -36163000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2017-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -36163000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36163000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312520059703/srra-20191231.xml#572257 Filing: 000119312520059703 The citation records this snapshot. The page link may show a newer release later.	USD 92,000 Exact value Exact value: 92000 USD 2017-01-01 – 2017-12-31: 92000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2017-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 92000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 92000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312520059703/srra-20191231.xml#572868 Filing: 000119312520059703 The citation records this snapshot. The page link may show a newer release later.	−USD 36.26 million Calculation and evidence -36163000 − 92000 USD Exact free cash flow: -36255000 USD 2017-01-01 – 2017-12-31: -36163000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 92000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2017-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -36255000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36163000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312520059703/srra-20191231.xml#572257 Filing: 000119312520059703 Input fundies:CapitalExpenditure: 92000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000119312520059703/srra-20191231.xml#572868 Filing: 000119312520059703 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 53.34 million Exact value Exact value: -53335000 USD 2018-01-01 – 2018-12-31: -53335000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2018-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -53335000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53335000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459021012234/srra-20201231.xml#169209 Filing: 000156459021012234 The citation records this snapshot. The page link may show a newer release later.	−USD 45.12 million Exact value Exact value: -45115000 USD 2018-01-01 – 2018-12-31: -45115000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2018-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -45115000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45115000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459021012234/srra-20201231.xml#193411 Filing: 000156459021012234 The citation records this snapshot. The page link may show a newer release later.	USD 118,000 Exact value Exact value: 118000 USD 2018-01-01 – 2018-12-31: 118000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2018-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 118000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 118000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459021012234/srra-20201231.xml#194039 Filing: 000156459021012234 The citation records this snapshot. The page link may show a newer release later.	−USD 45.23 million Calculation and evidence -45115000 − 118000 USD Exact free cash flow: -45233000 USD 2018-01-01 – 2018-12-31: -45115000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 118000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2018-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -45233000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45115000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459021012234/srra-20201231.xml#193411 Filing: 000156459021012234 Input fundies:CapitalExpenditure: 118000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459021012234/srra-20201231.xml#194039 Filing: 000156459021012234 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 88.28 million Exact value Exact value: -88275000 USD 2019-01-01 – 2019-12-31: -88275000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2019-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -88275000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -88275000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#1803345 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	−USD 51.18 million Exact value Exact value: -51183000 USD 2019-01-01 – 2019-12-31: -51183000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2019-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -51183000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51183000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2103604 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	USD 39,000 Exact value Exact value: 39000 USD 2019-01-01 – 2019-12-31: 39000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2019-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 39000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 39000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2114983 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	−USD 51.22 million Calculation and evidence -51183000 − 39000 USD Exact free cash flow: -51222000 USD 2019-01-01 – 2019-12-31: -51183000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 39000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2019-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -51222000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51183000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2103604 Filing: 000156459022009473 Input fundies:CapitalExpenditure: 39000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2114983 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 80.9 million Exact value Exact value: -80902000 USD 2020-01-01 – 2020-12-31: -80902000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2020-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -80902000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -80902000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#1916896 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	−USD 52.37 million Exact value Exact value: -52367000 USD 2020-01-01 – 2020-12-31: -52367000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2020-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -52367000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -52367000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2101631 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	USD 12,000 Exact value Exact value: 12000 USD 2020-01-01 – 2020-12-31: 12000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2020-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 12000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2113116 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	−USD 52.38 million Calculation and evidence -52367000 − 12000 USD Exact free cash flow: -52379000 USD 2020-01-01 – 2020-12-31: -52367000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 12000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2020-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -52379000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -52367000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2101631 Filing: 000156459022009473 Input fundies:CapitalExpenditure: 12000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2113116 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 94.66 million Exact value Exact value: -94659000 USD 2021-01-01 – 2021-12-31: -94659000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Net Income: -94659000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -94659000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#1992906 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	−USD 78.96 million Exact value Exact value: -78964000 USD 2021-01-01 – 2021-12-31: -78964000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Operating Cash Flow: -78964000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -78964000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2099658 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	USD 72,000 Exact value Exact value: 72000 USD 2021-01-01 – 2021-12-31: 72000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Capital Expenditure: 72000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 72000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2111249 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.	−USD 79.04 million Calculation and evidence -78964000 − 72000 USD Exact free cash flow: -79036000 USD 2021-01-01 – 2021-12-31: -78964000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 72000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Sierra Oncology, Inc. · 2021-12-31 Sierra Oncology, Inc. (edgar:1290149) Free cash flow: -79036000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:13:30Z Snapshot: 2b6d4f588986806a6d85cf8d91e36a8354932b36d1bb831bbe082a8f819c5ce1 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1290149?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -78964000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2099658 Filing: 000156459022009473 Input fundies:CapitalExpenditure: 72000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1290149/000156459022009473/srra-10k_20211231.htm#2111249 Filing: 000156459022009473 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 1,616 latest values · 1,616 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001290149, 1290149, DNAI, SRRA, edgar:1290149

Also known as ProNAi Therapeutics Inc, Sierra Oncology, Inc.

Sierra Oncology, Inc.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation